Style | Citing Format |
---|---|
MLA | Moradi S, et al.. "Pd-1/Pd-L1 Blockade Therapy With Atezolizumab: A New Paradigm in the Treatment of Non-Small Cell Lung Cancer (Nsclc)." Discover Oncology, vol. 16, no. 1, 2025, pp. -. |
APA | Moradi S, Sarikhani P, Albadr RJ, Taher WM, Alwan M, Jawad MJ, Mushtaq H, Vakilzadehian N (2025). Pd-1/Pd-L1 Blockade Therapy With Atezolizumab: A New Paradigm in the Treatment of Non-Small Cell Lung Cancer (Nsclc). Discover Oncology, 16(1), -. |
Chicago | Moradi S, Sarikhani P, Albadr RJ, Taher WM, Alwan M, Jawad MJ, Mushtaq H, Vakilzadehian N. "Pd-1/Pd-L1 Blockade Therapy With Atezolizumab: A New Paradigm in the Treatment of Non-Small Cell Lung Cancer (Nsclc)." Discover Oncology 16, no. 1 (2025): -. |
Harvard | Moradi S et al. (2025) 'Pd-1/Pd-L1 Blockade Therapy With Atezolizumab: A New Paradigm in the Treatment of Non-Small Cell Lung Cancer (Nsclc)', Discover Oncology, 16(1), pp. -. |
Vancouver | Moradi S, Sarikhani P, Albadr RJ, Taher WM, Alwan M, Jawad MJ, et al.. Pd-1/Pd-L1 Blockade Therapy With Atezolizumab: A New Paradigm in the Treatment of Non-Small Cell Lung Cancer (Nsclc). Discover Oncology. 2025;16(1):-. |
BibTex | @article{ author = {Moradi S and Sarikhani P and Albadr RJ and Taher WM and Alwan M and Jawad MJ and Mushtaq H and Vakilzadehian N}, title = {Pd-1/Pd-L1 Blockade Therapy With Atezolizumab: A New Paradigm in the Treatment of Non-Small Cell Lung Cancer (Nsclc)}, journal = {Discover Oncology}, volume = {16}, number = {1}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Moradi S AU - Sarikhani P AU - Albadr RJ AU - Taher WM AU - Alwan M AU - Jawad MJ AU - Mushtaq H AU - Vakilzadehian N TI - Pd-1/Pd-L1 Blockade Therapy With Atezolizumab: A New Paradigm in the Treatment of Non-Small Cell Lung Cancer (Nsclc) JO - Discover Oncology VL - 16 IS - 1 SP - EP - PY - 2025 ER - |